EARLY, PAIN-FREE CANCER DETECTION

X-ZELL is fusing next-generation single-cell detection technology with artificial intelligence to identify clinically significant cancers at the earliest stages – non-invasively, accurately and affordably.

TECHNOLOGY

X-ZELL’s single-cell diagnostics platform can isolate individual atypical cells from 10mL of blood and digitise the sample for AI-assisted cytopathological evaluation.

Find out more >

APPLICATION

X-ZELL’s single-cell diagnostic tests identify clinically significant cancers at the earliest stages, providing cytologists unprecedented single-cell data from whole blood.

Find out more >

SCIENCE

Tumours start shedding atypical single cells into the blood when they are only 1-2 mm in size. Isolating them for cytopathological evaluation could pave the way for affordable cancer screening.

Find out more >

X-ZELL is a proud partner of
X-ZELL Single-Cell Diagnostics

DETECTING 1 CELL IN 5 BILLION

10ml Blood In

X-ZELL Tech & AI

Data Out

Plug & play platform

Remove all healthy cells from 10 mL blood (~5 billion cells total) and expose individual atypical cells for digital analysis using deep-learning AI.

FIND OUT MORE

COMMITTED TO 
VISION ZERO

X-ZELL is committed to creating a world with zero deaths from undetected cancer – we call it Vision Zero.

X-ZELL

FIGHTING CANCER,
ONE CELL AT A TIME.

© 2022 X-ZELL INC

Find Us

XZELL HQ

Subscribe to the X-ZELL eUpdate

Subscribe to the X-ZELL eUpdate

Join our mailing list to receive the latest news and updates from X-ZELL Inc. 

 

Click here to Subscribe

You have Successfully Subscribed!